Navigation Links
STALLERGENES: 1st Half-Year 2009: Performance Ahead of Expectations
Date:8/26/2009

up share 11 19.6 10.6 3 19.7 EBITDA 12 37.5 20.2 56 - Capital expenditure 93 (21.6) (11.7) 130 - Free cash flow 45 4.9 2.6 (66) - Net financial debts (131) 9.5 (818) - Equity 23 109.0 17 - EPS, diluted 11 1.47 EUR 3 1.48 EUR Dividend rate -1017% 34% 8 34% Dividend per share - 0.50 EUR 11 0.50 EUR

Sales growth and financial position

In spite of the unfavourable economic background, sales were maintained at a high level (up 12% - 11% organic, excluding foreign exchange effect), due to the continuing growth of sublingual treatments. The launch of ORALAIR(R), which started at the end of 2008 in Germany, has confirmed its commercial success.

Selling, general and administrative expenses posted a moderate 8% increase, substantially offset by the growth in sales. The 29% increase in net R&D costs highlighted the continued dynamic development of allergen tablets. In this context, operating profit grew by 7% to EUR 19.6 million. Due to good control of financial expenses, net profit increased by 11% to EUR 13.4 million. Diluted earnings per share amounted to EUR 1.01.

EBITDA grew by 12% to EUR 24.1 million. Against a background of sustained investments, free cash flow rose by 45% to a positive EUR 14.5 million, particularly due to a reduction in working capital requirements. For the first time in 10 years, the net financial position was a positive EUR 1.3 million.

The half-year financial report can be downloaded from the corporate website: http://www.stallergen
'/>"/>

SOURCE Stallergenes
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. STALLERGENES: ORALAIR Grasses: Positive Results of VO52.06 Paediatric Study
2. STALLERGENES: 2007: A Further Year of Strong Growth: Up 16%
3. Stallergenes: Q2 2008 Sales up 18% Revision Upwards of 2008 Sales Growth
4. Stallergenes: First Half Year 2008: A 19% Increase in Operating Profit and Net Profit
5. Stallergenes: Sales at end September 2008: + 17% - 2008 Sales Guidance Revised Upwards: + 14%
6. Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009
7. Stallergenes: 2008: Sales Up 16% - Excellent Performance - Guidance Exceeded
8. STALLERGENES: 2008: Strong Performance
9. STALLERGENES: Strong Sales Growth in 1st Half-Year: up 12% Full-Year Guidance Maintained
10. BIO International Convention 2009: Research Location Germany Presents Potential in Regenerative Medicine
11. Jatrophaworld Training 2009: 2nd Generation nonfood Biofuel crops Knowledge Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... --   , ... KLOX    Mariano Rodriguez ... bestellt    KLOX ist bestens vorbereitet, ... Behandlungssystems zur Wundheilung zu beginnen    , ... erfreut, die folgenden personellen Veränderungen anzukündigen: ...
(Date:11/21/2014)... 2014 The science of light and ... with more than 200 primary students in a traveling ... University of Otago Physics Department and funded by an ... members of the university’s OSA/SPIE Student Chapter visited six ... giving children from small, rural schools hands-on lessons in ...
(Date:11/21/2014)... November 20, 2014 The ... policy research organization representing leading California academic institutions, ... PwC US today released a report ... sciences industry growth. The trend shows a 4 ... 2015 California Biomedical Industry Report indicates that, ...
(Date:11/21/2014)... Arkansas (PRWEB) November 20, 2014 ... Pinnacle Ozone Solutions, LLC (Pinnacle), and PCI, Inc., ... announced that they have been selected to provide ... of Fayetteville, Arkansas Paul R. Noland Wastewater Treatment. ... BlueInGreen’s patented HyDOZ® gas dissolution technology, ...
Breaking Biology Technology:KLOX Technologies meldet Neubesetzung von Führungspositionen 2KLOX Technologies meldet Neubesetzung von Führungspositionen 3KLOX Technologies meldet Neubesetzung von Führungspositionen 4KLOX Technologies meldet Neubesetzung von Führungspositionen 5Optics and photonics outreach programs share science, spark fascination with light 2Optics and photonics outreach programs share science, spark fascination with light 3California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 2California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 3California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 4City of Fayetteville Leads Nation with Innovative Ozone Technology 2City of Fayetteville Leads Nation with Innovative Ozone Technology 3City of Fayetteville Leads Nation with Innovative Ozone Technology 4
... LIUZHOU CITY, Guangxi, China , May ... Board: CNBI), ("China BCT" or the,"Company"), a leading pharmaceutical distributor, ... , China , today,announced results for the first quarter ... First Quarter 2010 Highlights, -- Revenue ...
... ... Sales Revenue" - a webinar focusing on essential internet tools and techniques used by eMarketers ... at 2PM EST. Registration for the event is free. For more information, visit ... ...
... and EMERYVILLE, Calif. , May 20 Bayer ... announced that more than 70 studies evaluating the use of Nexavar® (sorafenib) ... (ASCO) annual meeting in Chicago . , ... "Bayer and Onyx are encouraged by the number and ...
Cached Biology Technology:China BCT Reports First Quarter 2010 Results 2China BCT Reports First Quarter 2010 Results 3China BCT Reports First Quarter 2010 Results 4China BCT Reports First Quarter 2010 Results 5China BCT Reports First Quarter 2010 Results 6China BCT Reports First Quarter 2010 Results 7China BCT Reports First Quarter 2010 Results 8China BCT Reports First Quarter 2010 Results 9China BCT Reports First Quarter 2010 Results 10China BCT Reports First Quarter 2010 Results 11China BCT Reports First Quarter 2010 Results 12China BCT Reports First Quarter 2010 Results 13China BCT Reports First Quarter 2010 Results 14Healthcare Data Solutions Announces New Healthcare eMarketing Webinar 2Healthcare Data Solutions Announces New Healthcare eMarketing Webinar 3Nexavar Data to be Presented at 46th American Society of Clinical Oncology Annual Meeting 2Nexavar Data to be Presented at 46th American Society of Clinical Oncology Annual Meeting 3Nexavar Data to be Presented at 46th American Society of Clinical Oncology Annual Meeting 4Nexavar Data to be Presented at 46th American Society of Clinical Oncology Annual Meeting 5Nexavar Data to be Presented at 46th American Society of Clinical Oncology Annual Meeting 6Nexavar Data to be Presented at 46th American Society of Clinical Oncology Annual Meeting 7Nexavar Data to be Presented at 46th American Society of Clinical Oncology Annual Meeting 8
(Date:11/6/2014)... team of Florida State University biologists could lead to ... and survive environmental swings such as droughts or floods. ... the journal The Plant Cell , sheds light ... is organized in a cell and how plants regulate ... and others are turned off. , "If you understand ...
(Date:11/5/2014)... Fidel Santamaria, associate professor of biology in the ... researchers in the nation selected to receive a ... Grant for Exploratory Research (EAGER). The funding supports ... support researchers to create new technology that will ... Santamaria, complex behaviors in neuroscience are broken into ...
(Date:11/4/2014)... nature, the right amount of death at the right ... according to new research that could help in understanding ... stocks. , In a paper in the journal ... researcher and European colleagues conclude that the kind of ... loss of individuals, or mortality, depends on the size ...
Breaking Biology News(10 mins):Maize analysis yields whole new world of genetic science 2UTSA biology professor awarded $300,000 NSF grant for brain research 2UTSA biology professor awarded $300,000 NSF grant for brain research 3When less is more: Death in moderation boosts population density in nature 2
... a portion of Zion National Park in the past ... leading to severe ecological damage, loss of cottonwood trees, ... of environmental degradation, all linked to the decline of ... study to affect a broad range of terrestrial and ...
... Wake Forest University Baptist Medical Center and colleagues at ... multi-year study to identify genes that may contribute to ... in their teens and early adult life who have ... their risk factors for heart disease and stroke sooner ...
... of California, San Diego and Yale University have discovered ... bacterium sprayed on crops by organic farmers to reduce ... in laboratory animals. , Their discovery, detailed in ... the National Academy of Sciences, could pave the way ...
Cached Biology News:Cougar predation key to ecosystem health 2Cougar predation key to ecosystem health 3Cougar predation key to ecosystem health 4Scientists work to identify genes that contribute to early heart attack risk 2Bacterial protein shows promise in treating intestinal parasites 2Bacterial protein shows promise in treating intestinal parasites 3
... used to quantitate double-stranded DNA (dsDNA) in solution, ... With this kit, DNA is stained with Hoechst ... VersaFluor or other fluorometer. The kit quantitates dsDNA ... to 5 micrograms per ml and contains Hoechst ...
... stimulating factors for assays of mouse hematopoietic ... fetal liver. Suitable for the growth ... when added to methylcellulose at a final ... Will also support growth of mouse ...
ImmunoPure Plus Immobilized Protein G, , , , Support: Cross-linked 6%, beaded agarose , Capacity: > 20 mg human IgG/ml of gel ...
...
Biology Products: